GEG

Great Elm Group, Inc.

There isn't enough reported data to score GEG yet.

GEG Fundamentals

MetricStatus
Stable
Weak
Healthy
Strong

GEG's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is weak.

GEG PE Valuation

GEG has no meaningful PE right now: it lost money over the past year.

GEG Forward outlook

There aren't enough analyst estimates for GEG to show an outlook.

GEG Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $2.16 on Nov 12.

There is not enough scenario data to assess GEG's risk to reward.

GEG Earnings Per Share

Q4 2023: $0.35Q1 2024: $-0.15Q2 2024: $-0.05Q3 2024: $-0.05Q4 2024: $0.00Q1 2025: $-0.07Q2 2025: $0.38Q3 2025: $0.06Q4 2025: $-0.48Q1 2026: $-0.76Q2 2026: $-1.17Q3 2026: $-1.07
Q4 2023: $0.35Q1 2024: $-0.15Q2 2024: $-0.05Q3 2024: $-0.05Q4 2024: $0.00Q1 2025: $-0.07Q2 2025: $0.38Q3 2025: $0.06Q4 2025: $-0.48Q1 2026: $-0.76Q2 2026: $-1.17Q3 2026: $-1.07
QuarterTTM EPSYoY
Q3 2026-$1.07-1883%
Q2 2026-$1.17-408%
Q1 2026-$0.76-$0.69
Q4 2025-$0.48-$0.48
Q3 2025$0.06+$0.11
Q2 2025$0.38+$0.43
Q1 2025-$0.07+$0.08
Q4 2024$0.00-100%

GEG has swung to a loss: it lost $1.07 per share over the past year, after a profit the year before.

GEG Quarterly Revenue

Q4 2023: $3MQ1 2024: $3MQ2 2024: $9MQ3 2024: $4MQ4 2024: $4MQ1 2025: $3MQ2 2025: $6MQ3 2025: $11MQ4 2025: $3MQ1 2026: $3MQ2 2026: $11MQ3 2026: $3M
Q4 2023: $3MQ1 2024: $3MQ2 2024: $9MQ3 2024: $4MQ4 2024: $4MQ1 2025: $3MQ2 2025: $6MQ3 2025: $11MQ4 2025: $3MQ1 2026: $3MQ2 2026: $11MQ3 2026: $3M
QuarterRevenueYoY
Q3 2026$3.3M-69%
Q2 2026$10.6M+88%
Q1 2026$3.4M+6.5%
Q4 2025$3M-14%
Q3 2025$10.8M+170%
Q2 2025$5.6M-37%
Q1 2025$3.2M+15%
Q4 2024$3.5M+24%

GEG's revenue has slid since its 2022 peak: $3M last quarter, down 69% from the same quarter a year ago.

GEG Free Cash Flow

Q4 2023: −$14MQ1 2024: $1MQ2 2024: $3MQ3 2024: −$6MQ4 2024: −$4MQ1 2025: −$1MQ2 2025: $2MQ3 2025: $4MQ4 2025: −$2MQ1 2026: $6MQ2 2026: $8MQ3 2026: −$11M
Q4 2023: −$14MQ1 2024: $1MQ2 2024: $3MQ3 2024: −$6MQ4 2024: −$4MQ1 2025: −$1MQ2 2025: $2MQ3 2025: $4MQ4 2025: −$2MQ1 2026: $6MQ2 2026: $8MQ3 2026: −$11M
QuarterFree cash flowYoY
Q3 2026-$10.6M-378%
Q2 2026$7.9M+265%
Q1 2026$5.8M+$7.2M
Q4 2025-$1.9M+$2.2M
Q3 2025$3.8M+$9.6M
Q2 2025$2.2M-27%
Q1 2025-$1.3M-198%
Q4 2024-$4M+$9.7M

GEG usually generates cash, though not every quarter: the latest was −$11M, but it generated $1M over the past year.

GEG Total Shares

Q4 2023: 30MQ1 2024: 30MQ2 2024: 30MQ3 2024: 40MQ4 2024: 29MQ1 2025: 27MQ3 2025: 29MQ4 2025: 32MQ1 2026: 31MQ2 2026: 30MQ3 2026: 30M
Q4 2023: 30MQ1 2024: 30MQ2 2024: 30MQ3 2024: 40MQ4 2024: 29MQ1 2025: 27MQ3 2025: 29MQ4 2025: 32MQ1 2026: 31MQ2 2026: 30MQ3 2026: 30M
PeriodChange %Net change
Quarterly-1.8%-554K shares
1 year+2.6%+763K shares
3 years+2.5%+738K shares
5 years+15%+4M shares
Available history+17%+4.3M shares

GEG has 30M diluted shares, up 2.6% from a year ago, despite $7M in buybacks over the past year.

GEG Net Leverage

QuarterNet LeverageStatus
Q2 2022-15.6xNet Cash
Q1 2022-12.4xNet Cash
Q4 2021-6.4xNet Cash
Q3 2021-4.3xNet Cash
Q4 20198.6xHigh

GEG has more cash than debt.

GEG Weekly Momentum

MetricValueStatus
RSI48.2Neutral
Stochastic22.8Neutral

GEG's weekly RSI is 48 (neutral) and its Stochastic is 23 (neutral).

GEG PE vs Healthcare Sector

MetricGEGSector medianRelative
PEN/A26x—

GEG has no meaningful PE right now: it lost money over the past year.

GEG Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$2.160% above
20 week MA$2.170.5% below
50 week MA$2.201.8% below
100 week MA$2.170.5% below
200 week MA$2.064.9% above

GEG has fallen below most of its moving averages, though it's still 4.9% above its 200-week average.

GEG Yearly ROI

YearStart priceEnd priceROI
2020$3.48$2.72-22%
2021$2.72$2.07-24%
2022$2.07$1.99-3.9%
2023$1.99$1.94-2.5%
2024$1.94$1.82-6.2%
2025$1.82$2.44+34%
2026 YTD$2.44$2.16-11%

GEG has finished lower in five of the last six years. It's down 11% so far in 2026.

Give your agent the market.

Get API key